Q3 FY2026 · ended Sep 30, 2026 · Revenue $1.55B, +18.8% YoY · Filed Nov 4, 2026
Albemarle Corporation (ALB) files with the SEC under industry code 2821, Plastic Materials, Synth Resins & Nonvulcan Elastomers. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $1.6 billion and net income of $296.8 million. Free cash flow was $325.4 million. As of Sep 30, 2026 it held $2.9 billion in cash and investments and $2.1 billion in total debt.
Company profile
- Industry
- Plastic Materials, Synth Resins & Nonvulcan Elastomers (SIC 2821)
- Listed as
- ALB (NYSE), ALB-PA (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- VA
- Headquarters
- Charlotte, NC
- SEC filer status
- Large accelerated filer
- SEC CIK
- 915913
Other Plastic Materials, Synth Resins & Nonvulcan Elastomers companies
- Dow Inc. DOW
- DuPont de Nemours, Inc. DD
- Eastman Chemical Co EMN
- Hexcel Corp /DE/ HXL
- Avient Corp AVNT
- Rogers Corp ROG
- PureCycle Technologies, Inc. PCT
- AdvanSix Inc. ASIX
All 12 Plastic Materials, Synth Resins & Nonvulcan Elastomers companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $1.6B | $1.7B | $1.4B | $1.4B | $1.3B |
| Operating income | $148.2M | $452.9M | $233.5M | -$217.4M | -$217.0M |
| Net income | $296.8M | $480.0M | $319.1M | -$414.2M | -$160.7M |
| Diluted EPS | $2.15 | $3.52 | $2.34 | -$3.87 | -$1.72 |
| Operating cash flow | $405.8M | $710.0M | $346.2M | $388.5M | $355.6M |
| Free cash flow | $325.4M | $638.3M | $247.6M | $233.1M | $223.4M |
| Total assets | $16.1B | $15.9B | $15.1B | $16.4B | $17.1B |
| Stockholders' equity | $10.5B | $10.3B | $9.9B | $9.5B | $10.0B |
| Cash and investments | $2.9B | $2.7B | $2.1B | $900.9M | $2.8B |
| Total debt | $2.1B | $2.1B | $2.1B | $3.4B | $3.9B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt, Bylaw or fiscal year change
|
Oct 30, 2026 | Oct 26, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 3, 2026 | Sep 2, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 21, 2026 | Aug 19, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
All 1006 Albemarle Corporation SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.